Oncol-话题@MedSci

#Oncol#

2384篇内容 | 2467人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1866618, encodeId=c7b6186661805, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤, objectType=article, longId=727924, objectId=0dbbe2792428, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0dbbe2792428, replyNumber=0, likeNumber=94, createdTime=2023-02-20, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0dbbe2792428, moduleTitle=JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0dbbe2792428)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866620, encodeId=4f851866620fb, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：信迪利单抗联合安罗替尼作为二线或后线治疗PD-L1阳性复发或转移(R/M) 宫颈癌的疗效和安全性, objectType=article, longId=728373, objectId=4ee9e283734e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee9e283734e, replyNumber=0, likeNumber=98, createdTime=2022-10-18, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee9e283734e, moduleTitle=J Clin Oncol：信迪利单抗联合安罗替尼作为二线或后线治疗PD-L1阳性复发或转移(R/M) 宫颈癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee9e283734e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866412, encodeId=99f8186641254, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：早发型结直肠癌患者的治疗依从性优于晚发型，但预后更差！, objectType=article, longId=291935, objectId=ce7829193597, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ce7829193597, replyNumber=0, likeNumber=52, createdTime=2021-12-25, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce7829193597, moduleTitle=J Clin Oncol：早发型结直肠癌患者的治疗依从性优于晚发型，但预后更差！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce7829193597)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866502, encodeId=1419186650244, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：PIK3CA激活突变肿瘤的新药物——Copanlisib！, objectType=article, longId=295439, objectId=db26295439f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db26295439f3, replyNumber=0, likeNumber=0, createdTime=2022-06-06, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db26295439f3, moduleTitle=J Clin Oncol：PIK3CA激活突变肿瘤的新药物——Copanlisib！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db26295439f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866399, encodeId=9b0e18663995a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Front Oncol：真实世界研究分析黑色素瘤患者抗PD-1治疗免疫相关不良事件与疗效的关系, objectType=article, longId=221570, objectId=2dff2215e066, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dff2215e066, replyNumber=0, likeNumber=80, createdTime=2022-01-31, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dff2215e066, moduleTitle=Front Oncol：真实世界研究分析黑色素瘤患者抗PD-1治疗免疫相关不良事件与疗效的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dff2215e066)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866649, encodeId=92a21866649f8, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：接受血液或骨髓移植治疗的急性髓系白血病幸存者的长期疾病负担, objectType=article, longId=730445, objectId=62f9e304450a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62f9e304450a, replyNumber=0, likeNumber=54, createdTime=2022-08-26, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62f9e304450a, moduleTitle=J Clin Oncol：接受血液或骨髓移植治疗的急性髓系白血病幸存者的长期疾病负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62f9e304450a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866401, encodeId=ba581866401ff, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Eur Urol Oncol：局部消融放疗在寡转移PCa患者中的疗效如何？, objectType=article, longId=221585, objectId=aaf22215856f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaf22215856f, replyNumber=0, likeNumber=75, createdTime=2022-10-06, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaf22215856f, moduleTitle=Eur Urol Oncol：局部消融放疗在寡转移PCa患者中的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaf22215856f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866610, encodeId=4bed18666101a, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测, objectType=article, longId=727390, objectId=19e3e2739016, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e3e2739016, replyNumber=0, likeNumber=76, createdTime=2022-12-25, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e3e2739016, moduleTitle=Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19e3e2739016)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866710, encodeId=0f241866e10fb, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：奥拉帕尼维持治疗晚期卵巢癌随访长达7年的总生存预后, objectType=article, longId=739397, objectId=5287e39397ac, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5287e39397ac, replyNumber=0, likeNumber=89, createdTime=2023-08-17, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5287e39397ac, moduleTitle=J Clin Oncol：奥拉帕尼维持治疗晚期卵巢癌随访长达7年的总生存预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5287e39397ac)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866577, encodeId=77a118665e794, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Eur Urol Oncol：免疫环境和分化特征可预测膀胱癌结局, objectType=article, longId=302149, objectId=71f930214973, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71f930214973, replyNumber=0, likeNumber=80, createdTime=2022-08-30, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71f930214973, moduleTitle=Eur Urol Oncol：免疫环境和分化特征可预测膀胱癌结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=71f930214973)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866576, encodeId=db1218665e655, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：Gorlin综合征的早期临床特征可预测后期的严重程度, objectType=article, longId=302191, objectId=1ff6302191c4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1ff6302191c4, replyNumber=0, likeNumber=71, createdTime=2022-12-21, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1ff6302191c4, moduleTitle=J Clin Oncol：Gorlin综合征的早期临床特征可预测后期的严重程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1ff6302191c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866515, encodeId=d69b186651580, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：博纳吐单抗诱导巩固+POMP维持治疗Ph染色体阴性B-ALL老年患者的疗效, objectType=article, longId=299130, objectId=317729913045, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=317729913045, replyNumber=0, likeNumber=76, createdTime=2022-04-06, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=317729913045, moduleTitle=J Clin Oncol：博纳吐单抗诱导巩固+POMP维持治疗Ph染色体阴性B-ALL老年患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=317729913045)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866465, encodeId=a55b1866465b9, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Eur Urol Oncol：膀胱内VPM1002BC治疗常规BCG治疗后的非肌层浸润性膀胱癌(NMIBC)复发, objectType=article, longId=294582, objectId=5111294582d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5111294582d5, replyNumber=0, likeNumber=96, createdTime=2022-12-02, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5111294582d5, moduleTitle=Eur Urol Oncol：膀胱内VPM1002BC治疗常规BCG治疗后的非肌层浸润性膀胱癌(NMIBC)复发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5111294582d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866588, encodeId=2ba11866588b5, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Lancet Oncol：大剂量放疗+长期雄激素剥夺治疗前列腺癌的10年随访结果, objectType=article, longId=724218, objectId=c68de2421877, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c68de2421877, replyNumber=0, likeNumber=60, createdTime=2022-11-07, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c68de2421877, moduleTitle=Lancet Oncol：大剂量放疗+长期雄激素剥夺治疗前列腺癌的10年随访结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c68de2421877)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866624, encodeId=0f3018666243b, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶, objectType=article, longId=728635, objectId=9e8ce2863581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e8ce2863581, replyNumber=0, likeNumber=94, createdTime=2022-12-22, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e8ce2863581, moduleTitle=Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e8ce2863581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866707, encodeId=34041866e07e2, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值, objectType=article, longId=738658, objectId=9f99e3865805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9f99e3865805, replyNumber=0, likeNumber=70, createdTime=2022-12-23, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9f99e3865805, moduleTitle=JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9f99e3865805)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866569, encodeId=33151866569de, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Thorac Oncol: TP53共突变促进EGFR突变肺腺癌的耐药进化, objectType=article, longId=301646, objectId=b80230164678, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b80230164678, replyNumber=0, likeNumber=84, createdTime=2022-04-19, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b80230164678, moduleTitle=J Thorac Oncol: TP53共突变促进EGFR突变肺腺癌的耐药进化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b80230164678)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866658, encodeId=20bd18666584c, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Frontiers in Oncology：蘑菇有奇效！研究表明蘑菇提取物可清除HPV感染, objectType=article, longId=731835, objectId=a298e318356a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a298e318356a, replyNumber=0, likeNumber=81, createdTime=2023-01-29, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a298e318356a, moduleTitle=Frontiers in Oncology：蘑菇有奇效！研究表明蘑菇提取物可清除HPV感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a298e318356a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866644, encodeId=44d7186664447, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=Ann Oncol：派姆单抗治疗多种MSI-H/dMMR实体肿瘤的疗效和安全性, objectType=article, longId=729827, objectId=8d36e298275b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d36e298275b, replyNumber=0, likeNumber=80, createdTime=2022-07-01, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d36e298275b, moduleTitle=Ann Oncol：派姆单抗治疗多种MSI-H/dMMR实体肿瘤的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d36e298275b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1866397, encodeId=ea93186639e03, content=<a href='/topic/show?id=16ce133504e' target=_blank style='color:#2F92EE;'>#Oncol#</a>, objectTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, objectType=article, longId=221539, objectId=ea642215396a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea642215396a, replyNumber=0, likeNumber=67, createdTime=2022-01-13, rootId=0, userName=minlingfeng, userId=b63894, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea642215396a, moduleTitle=J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea642215396a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Oncol

2020-05-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：抗表皮生长因子受体抗体药物偶联物MRG003治疗晚期实体瘤

2023-02-20

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：信迪利单抗联合安罗替尼作为二线或后线治疗PD-L1阳性复发或转移(R/M) 宫颈癌的疗效和安全性

2022-10-18

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：早发型结直肠癌患者的治疗依从性优于晚发型，但预后更差！

2021-12-25

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：PIK3CA激活突变肿瘤的新药物——Copanlisib！

2022-06-06

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Front Oncol：真实世界研究分析黑色素瘤患者抗PD-1治疗免疫相关不良事件与疗效的关系

2022-01-31

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：接受血液或骨髓移植治疗的急性髓系白血病幸存者的长期疾病负担

2022-08-26

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Eur Urol Oncol：局部消融放疗在寡转移PCa患者中的疗效如何？

2022-10-06

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Eur Urol Oncol：高危上尿路尿道癌根治术后的肿瘤学监测

2022-12-25

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：奥拉帕尼维持治疗晚期卵巢癌随访长达7年的总生存预后

2023-08-17

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Eur Urol Oncol：免疫环境和分化特征可预测膀胱癌结局

2022-08-30

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：Gorlin综合征的早期临床特征可预测后期的严重程度

2022-12-21

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：博纳吐单抗诱导巩固+POMP维持治疗Ph染色体阴性B-ALL老年患者的疗效

2022-04-06

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Eur Urol Oncol：膀胱内VPM1002BC治疗常规BCG治疗后的非肌层浸润性膀胱癌(NMIBC)复发

2022-12-02

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Lancet Oncol：大剂量放疗+长期雄激素剥夺治疗前列腺癌的10年随访结果

2022-11-07

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Lancet Oncol：复发/难治性慢性淋巴细胞白血病采用维奈托克+依鲁替尼治疗的“开关”——最小残留病灶

2022-12-22

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

JAMA Oncol：PD-L1表达水平对晚期胃食管癌患者从ICI治疗中获益的预测价值

2022-12-23

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Thorac Oncol: TP53共突变促进EGFR突变肺腺癌的耐药进化

2022-04-19

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Frontiers in Oncology：蘑菇有奇效！研究表明蘑菇提取物可清除HPV感染

2023-01-29

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

Ann Oncol：派姆单抗治疗多种MSI-H/dMMR实体肿瘤的疗效和安全性

2022-07-01

minlingfeng (审核中...)

前往app查看评论内容

#Oncol#

J Clin Oncol：PD-L1低表达的晚期胃或食管腺癌(GEAC)患者免疫检查点抑制剂（ICI）的疗效

2022-01-13

科室
- - 订阅+
  - 更多科室
工具
服务